Is Kalvista Pharmaceuticals Inc (KALV) a Leader in the Healthcare Sector?

Kalvista Pharmaceuticals Inc (KALV) is around the top of the Healthcare sector according to InvestorsObserver. KALV received an overall rating of 63, which means that it scores higher than 63% of stocks. Additionally, Kalvista Pharmaceuticals Inc scored a 89 in the Healthcare sector, ranking it higher than 89% of stocks in that sector.

KALV has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on KALV!

See Full KALV Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kalvista Pharmaceuticals Inc Stock Today?

Kalvista Pharmaceuticals Inc (KALV) stock has fallen -1.59% while the S&P 500 is up 0.21% as of 12:03 PM on Tuesday, Nov 7. KALV is lower by -$0.14 from the previous closing price of $8.50 on volume of 195,380 shares. Over the past year the S&P 500 is up 14.93% while KALV is up 57.04%. KALV lost -$3.16 per share the over the last 12 months. Click Here to get the full Stock Report for Kalvista Pharmaceuticals Inc stock.